메뉴 건너뛰기




Volumn 85, Issue 37, 2005, Pages 2629-2635

The role of local immune response in gastric mucosa in the protection induced by Helicobacter pylori vaccine with chitosan as adjuvant

Author keywords

Adjuvant, immunologic; Chitosan; Helicobacter pylori; Vaccines

Indexed keywords

ADJUVANT; CHITOSAN; CHOLERA TOXIN; HELICOBACTER PYLORI VACCINE; IMMUNOGLOBULIN A; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; PARAFFIN;

EID: 27644462209     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (1)

References (15)
  • 1
    • 0035842940 scopus 로고    scopus 로고
    • To regard immune treatment and prevention of Helicobacter pylori infection
    • Hu FL. To regard immune treatment and prevention of Helicobacter pylori infection. Natl Med J China, 2001 81:1409-1410.
    • (2001) Natl. Med. J. China , vol.81 , pp. 1409-1410
    • Hu, F.L.1
  • 2
    • 1242270653 scopus 로고    scopus 로고
    • Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans: Enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosan
    • McNeela EA, Jabbal-Gill I, Illum L, et al. Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans: enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosan. Vaccine, 2004, 22: 909-914.
    • (2004) Vaccine , vol.22 , pp. 909-914
    • McNeela, E.A.1    Jabbal-Gill, I.2    Illum, L.3
  • 3
    • 1842555353 scopus 로고    scopus 로고
    • Novel chitosan particles and chitosan-coated emulsions inducing immune response via intranasal vaccine delivery
    • Nagamoto T, Hattori Y, Takayama K, et al. Novel chitosan particles and chitosan-coated emulsions inducing immune response via intranasal vaccine delivery. Pharm Res, 2004, 21: 671-674.
    • (2004) Pharm. Res. , vol.21 , pp. 671-674
    • Nagamoto, T.1    Hattori, Y.2    Takayama, K.3
  • 4
    • 0346094226 scopus 로고    scopus 로고
    • Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice
    • Vila A, Sanchez A, Janes K, et al. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. Eur J Pharm Biopharm, 2004, 57: 123-131.
    • (2004) Eur. J. Pharm. Biopharm. , vol.57 , pp. 123-131
    • Vila, A.1    Sanchez, A.2    Janes, K.3
  • 5
    • 0034823205 scopus 로고    scopus 로고
    • Chitosan and its derivatives in mucosal drug and vaccine delivery
    • Lubben IM, Verhoef JC, Borchard G, et al Chitosan and its derivatives in mucosal drug and vaccine delivery. Eur J Pharm Sci, 2001, 14: 201-207.
    • (2001) Eur. J. Pharm. Sci. , vol.14 , pp. 201-207
    • Lubben, I.M.1    Verhoef, J.C.2    Borchard, G.3
  • 6
    • 0030901437 scopus 로고    scopus 로고
    • Alveolar macrophage priming by intravenous administration of chitin particles, polymers of N-acetyl-D-glucosamine, in mice
    • Shibata Y, Foster LA, Metzger WJ, et al. Alveolar macrophage priming by intravenous administration of chitin particles, polymers of N-acetyl-D-glucosamine, in mice. Infect Immun, 1997, 65: 1734-1741.
    • (1997) Infect. Immun. , vol.65 , pp. 1734-1741
    • Shibata, Y.1    Foster, L.A.2    Metzger, W.J.3
  • 7
    • 0035851974 scopus 로고    scopus 로고
    • ProJuvant (Pluronic F127/chitosan) enhances the immune response to intranasally administered tetanus toxoid
    • Westerink MA, Smithson SL, Srivastava N, et al. ProJuvant (Pluronic F127/chitosan) enhances the immune response to intranasally administered tetanus toxoid. Vaccine, 2001, 20: 711-723.
    • (2001) Vaccine , vol.20 , pp. 711-723
    • Westerink, M.A.1    Smithson, S.L.2    Srivastava, N.3
  • 8
    • 0030451867 scopus 로고    scopus 로고
    • Atrophic gastric changes in both Helicobacter felis and Helicobacter pylori infected mice are host dependent and separate from antral gastritis
    • Sakagami T, Dixon M, O'Rourke J, et al. Atrophic gastric changes in both Helicobacter felis and Helicobacter pylori infected mice are host dependent and separate from antral gastritis. Gut, 1996, 39: 639-648.
    • (1996) Gut , vol.39 , pp. 639-648
    • Sakagami, T.1    Dixon, M.2    O'Rourke, J.3
  • 9
    • 0037304911 scopus 로고    scopus 로고
    • Protective levels of diphtheria-neutralizing antibody induced in healthy volunteers by unilateral priming-boosting intranasal immunization associated with restricted ipsilateral mucosal secretory immunoglobulin a
    • Mills KH, Cosgrove C, McNeela EA, et al. Protective levels of diphtheria-neutralizing antibody induced in healthy volunteers by unilateral priming-boosting intranasal immunization associated with restricted ipsilateral mucosal secretory immunoglobulin a. Infect Immun, 2003,71:726-732.
    • (2003) Infect. Immun. , vol.71 , pp. 726-732
    • Mills, K.H.1    Cosgrove, C.2    McNeela, E.A.3
  • 10
    • 0032900511 scopus 로고    scopus 로고
    • Local secretory immunoglobulin A and postimmunization gastritis correlate with protection against Helicobacter pylori infection after oral vaccination of mice
    • Goto T, Nishizono A, Fujioka T, et al. Local secretory immunoglobulin A and postimmunization gastritis correlate with protection against Helicobacter pylori infection after oral vaccination of mice. Infect Immun, 1999, 67:2531-2539.
    • (1999) Infect. Immun. , vol.67 , pp. 2531-2539
    • Goto, T.1    Nishizono, A.2    Fujioka, T.3
  • 11
    • 0030775978 scopus 로고    scopus 로고
    • Murine CD4 T-cell response to Helicobacter pylori infection: Th1 cells enhance gastritis and Th2 cells reduce bacterial load
    • Mohammadi M, Nedrud J, Redline R, et al. Murine CD4 T-cell response to Helicobacter pylori infection: Th1 cells enhance gastritis and Th2 cells reduce bacterial load. Gastroenterology, 1997, 113: 1848-1857.
    • (1997) Gastroenterology , vol.113 , pp. 1848-1857
    • Mohammadi, M.1    Nedrud, J.2    Redline, R.3
  • 12
    • 0345669742 scopus 로고    scopus 로고
    • Protective efficacy of anti-Helicobacter pylori immunity following systemic immunization of neonatal mice
    • Eisenberg JC, Czinn SJ, Garhart CA, et al. Protective efficacy of anti-Helicobacter pylori immunity following systemic immunization of neonatal mice. Infect Immun, 2003, 71: 1820-1827.
    • (2003) Infect. Immun. , vol.71 , pp. 1820-1827
    • Eisenberg, J.C.1    Czinn, S.J.2    Garhart, C.A.3
  • 13
    • 0842347929 scopus 로고    scopus 로고
    • Systemic Th1 immunization of mice against Helicobacter pylori infection with CpG oligodeoxynucleotides as adjuvants does not protect from infection but enhances gastritis
    • Sommer F, Wilken H, Faller G, et al. Systemic Th1 immunization of mice against Helicobacter pylori infection with CpG oligodeoxynucleotides as adjuvants does not protect from infection but enhances gastritis. Infect Immun, 2004, 72: 1029-1035.
    • (2004) Infect. Immun. , vol.72 , pp. 1029-1035
    • Sommer, F.1    Wilken, H.2    Faller, G.3
  • 14
    • 1542494141 scopus 로고    scopus 로고
    • The role of Th12type response andγ2interferon in the protection induced by Helicobacter pylori vaccine
    • Shi T, Liu WZ, Shi GY, et al. The role of Th12type response andγ2interferon in the protection induced by Helicobacter pylori vaccine. Natl Med J China, 2003,83:1321-1325.
    • (2003) Natl. Med. J. China , vol.83 , pp. 1321-1325
    • Shi, T.1    Liu, W.Z.2    Shi, G.Y.3
  • 15
    • 27644517899 scopus 로고    scopus 로고
    • Th type immune response induced by Helicobacter pylori vaccine in mice
    • Chen J, Chen MH, Li GQ, et al. Th type immune response induced by Helicobacter pylori vaccine in mice. Chin J Dig, 2003,23:739-743.
    • (2003) Chin. J. Dig. , vol.23 , pp. 739-743
    • Chen, J.1    Chen, M.H.2    Li, G.Q.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.